Simplex Trading’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,789
| Closed | -$33K | – | 10648 |
|
|
2022
Q4 | $33K | Sell |
5,789
-473
| -8% | -$2.49K | ﹤0.01% | 6362 |
|
|
2022
Q3 | $41K | Buy |
6,262
+6,118
| +4,249% | +$37.1K | ﹤0.01% | 6723 |
|
|
2022
Q2 | $0 | Sell |
144
-8,324
| -98% | -$32.9K | ﹤0.01% | 11564 |
|
|
2022
Q1 | $28K | Buy |
+8,468
| New | +$26.8K | ﹤0.01% | 7881 |
|
|
2021
Q4 | – | Sell |
-17,288
| Closed | -$57.5K | – | 11783 |
|
|
2021
Q3 | $70K | Hold |
17,288
| – | – | ﹤0.01% | 7096 |
|
|
2021
Q2 | $72K | Buy |
17,288
+6,176
| +56% | +$26.1K | ﹤0.01% | 7185 |
|
|
2021
Q1 | $55K | Buy |
+11,112
| New | +$89.8K | ﹤0.01% | 6504 |
|
|
2020
Q3 | – | Sell |
-1,220
| Closed | -$12K | – | 8768 |
|
|
2020
Q2 | $12K | Sell |
1,220
-731
| -37% | -$7.01K | ﹤0.01% | 6573 |
|
|
2020
Q1 | $17K | Sell |
1,951
-12,654
| -87% | -$125K | ﹤0.01% | 6106 |
|
|
2019
Q4 | $134K | Buy |
14,605
+8,048
| +123% | +$57K | ﹤0.01% | 4198 |
|
|
2019
Q3 | $38K | Buy |
6,557
+5,349
| +443% | +$56.8K | ﹤0.01% | 5291 |
|
|
2019
Q2 | $14K | Buy |
+1,208
| New | +$13K | ﹤0.01% | 5920 |
|
|
2019
Q1 | – | Sell |
-21
| Closed | -$309 | – | 8101 |
|
|
2018
Q4 | $0 | Sell |
21
-80
| -79% | -$1.1K | ﹤0.01% | 8081 |
|
|
2018
Q3 | $1K | Sell |
101
-3,764
| -97% | -$59.2K | ﹤0.01% | 7253 |
|
|
2018
Q2 | $65K | Buy |
+3,865
| New | +$75.1K | ﹤0.01% | 4768 |
|
|
2018
Q1 | – | Sell |
-18
| Closed | -$400 | – | 7106 |
|
|
2017
Q4 | $0 | Sell |
18
-15,040
| -100% | -$303K | ﹤0.01% | 6921 |
|
|
2017
Q3 | $222K | Buy |
15,058
+10,378
| +222% | +$151K | 0.01% | 1126 |
|
|
2017
Q2 | $65K | Buy |
4,680
+3,217
| +220% | +$47.4K | ﹤0.01% | 2149 |
|
|
2017
Q1 | $24K | Buy |
+1,463
| New | +$17.5K | ﹤0.01% | 3084 |
|
|
2016
Q1 | – | Sell |
-2,485
| Closed | -$35.8K | – | 6453 |
|
|
2015
Q4 | $47K | Buy |
+2,485
| New | +$54K | ﹤0.01% | 1964 |
|
Simplex Trading's CNCE Position: Q1 2023 in Review
Simplex Trading sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 5,789 shares — an estimated $33K sold.
Simplex Trading first reported a position in CNCE in Q4 2015 and held it in 20 quarters. The position peaked at $222K in Q3 2017. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- Simplex Trading reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Simplex Trading sold 5,789 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $33K.
- Simplex Trading first reported a position in Concert Pharmaceuticals, Inc. in Q4 2015 and held it in 20 quarters.
- Simplex Trading's Concert Pharmaceuticals, Inc. position peaked at $222K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.